Elagib KE - Search Results

1

Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes.

Elagib KE, Brock A, Clementelli CM, Mosoyan G, Delehanty LL, Sahu RK, Pacheco-Benichou A, Fruit C, Besson T, Morris SW, Eto K, Jobaliya C, French DL, Gadue P, Singh S, Shi X, Qin F, Cornelison R, Li H, Iancu-Rubin C, Goldfarb AN. Elagib KE, et al. J Clin Invest. 2022 Oct 3;132(19):e154839. doi: 10.1172/JCI154839. J Clin Invest. 2022. PMID: 35925681 Free PMC article.

2

Cyclic AMP signaling inhibits megakaryocytic differentiation by targeting transcription factor 3 (E2A) cyclin-dependent kinase inhibitor 1A (CDKN1A) transcriptional axis.

Rubinstein JD, Elagib KE, Goldfarb AN. Rubinstein JD, et al. Among authors: elagib ke. J Biol Chem. 2012 Jun 1;287(23):19207-15. doi: 10.1074/jbc.M112.366476. Epub 2012 Apr 17. J Biol Chem. 2012. PMID: 22514271 Free PMC article.

3

Megakaryocytic irreversible P-TEFb activation.

Elagib KE, Goldfarb AN. Elagib KE, et al. Cell Cycle. 2014;13(12):1827-8. doi: 10.4161/cc.29324. Epub 2014 May 27. Cell Cycle. 2014. PMID: 24866976 Free PMC article. No abstract available.

4

Neonatal expression of RNA-binding protein IGF2BP3 regulates the human fetal-adult megakaryocyte transition.

Elagib KE, Lu CH, Mosoyan G, Khalil S, Zasadzińska E, Foltz DR, Balogh P, Gru AA, Fuchs DA, Rimsza LM, Verhoeyen E, Sansó M, Fisher RP, Iancu-Rubin C, Goldfarb AN. Elagib KE, et al. J Clin Invest. 2017 Jun 1;127(6):2365-2377. doi: 10.1172/JCI88936. Epub 2017 May 8. J Clin Invest. 2017. PMID: 28481226 Free PMC article.

5

Megakaryocyte ontogeny: Clinical and molecular significance.

Elagib KE, Brock AT, Goldfarb AN. Elagib KE, et al. Exp Hematol. 2018 May;61:1-9. doi: 10.1016/j.exphem.2018.02.003. Epub 2018 Mar 2. Exp Hematol. 2018. PMID: 29501467 Free PMC article. Review.

6

Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1.

Choi Y, Elagib KE, Delehanty LL, Goldfarb AN. Choi Y, et al. Among authors: elagib ke. Cancer Res. 2006 Mar 15;66(6):2990-6. doi: 10.1158/0008-5472.CAN-05-2944. Cancer Res. 2006. PMID: 16540647

7

AML-1-ETO-Mediated erythroid inhibition: new paradigms for differentiation blockade by a leukemic fusion protein.

Choi Y, Elagib KE, Goldfarb AN. Choi Y, et al. Among authors: elagib ke. Crit Rev Eukaryot Gene Expr. 2005;15(3):207-16. doi: 10.1615/critreveukargeneexpr.v15.i3.30. Crit Rev Eukaryot Gene Expr. 2005. PMID: 16390317 Review.

8

RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.

Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, Goldfarb AN. Elagib KE, et al. Blood. 2003 Jun 1;101(11):4333-41. doi: 10.1182/blood-2002-09-2708. Epub 2003 Feb 6. Blood. 2003. PMID: 12576332 Free article.

9

Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation.

Elagib KE, Goldfarb AN. Elagib KE, et al. Cancer Lett. 2007 Jun 28;251(2):179-86. doi: 10.1016/j.canlet.2006.10.010. Epub 2006 Nov 27. Cancer Lett. 2007. PMID: 17125917 Free PMC article. Review.

10

Regulation of RUNX1 transcriptional function by GATA-1.

Elagib KE, Goldfarb AN. Elagib KE, et al. Crit Rev Eukaryot Gene Expr. 2007;17(4):271-80. doi: 10.1615/critreveukargeneexpr.v17.i4.20. Crit Rev Eukaryot Gene Expr. 2007. PMID: 17725493 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page